< Back to the Blog

About the author

Ioana Calcev
Ioana Calcev is Chief Operating Officer at Oova. She's dedicated to empowering women with the data and insights they need to understand their hormone health and advocate for better care.

Sources

  1. The Menopause Society. The 2023 Nonhormone Therapy Position Statement. Menopause. 2023;30(6):573-590.
  2. U.S. Food and Drug Administration. FDA adds a boxed warning for rare serious liver injury with Veozah. Updated December 16, 2024.
  3. U.S. Food and Drug Administration. Veozah prescribing information. Revised December 2024.
  4. U.S. Food and Drug Administration. Lynkuet prescribing information. Revised October 2025.
  5. The Menopause Society. Genitourinary Syndrome of Menopause MenoNote. May 2025.
  6. Green SM, et al. Cognitive behavior therapy for menopausal symptoms: A randomized controlled trial. Menopause. 2019.
  7. Krieger L. Millions of Women Are Left Out of Menopause’s Moment. The New York Times. June 15, 2026. Included for patient experience and cultural context, not clinical guidance.

About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.